Advaxis Inc.

0.0620-0.0099-13.77%Vol 1.31M1Y Perf -86.17%
Jun 3rd, 2022 15:59 DELAYED
BID0.00 ASK0.00
Open0.0750 Previous Close0.0719
Pre-Market- After-Market-
 - -  - -%
Target Price
4.30 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
★★★★+ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★★     62.36
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     39.79
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.07 
Earnings Rating
Buy
Market Cap9.03M 
Earnings Date
13th Jun 2022
Alpha Standard Deviation
Beta 

Today's Price Range

0.06200.0900

52W Range

0.05500.7100

5 Year PE Ratio Range

-1.5074.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-
1 Month
-
3 Months
-
6 Months
-
1 Year
-86.17%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ADXS0.0620-0.0099-13.77
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
13.60
14.40
0.00
0.00
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-
-3 133.60
-3 053.60
-4 574.70
-83.61
RevenueValueIndustryS&P 500US Markets
500.00K
0.27
-61.31
-42.25
Earnings HistoryEstimateReportedSurprise %
Q03 2021--0.02-
Q02 2021--0.04-
Q01 2021--0.05-
Q04 2020--0.08-
Q03 2020--0.09-
Q02 2020--0.10-
Q01 2020--0.15-
Q04 2019--0.15-
Earnings Per EndEstimateRevision %Trend
10/2019 QR-1.370.00-
10/2019 FY-2.700.00-
1/2020 QR-0.630.00-
10/2020 FY-2.410.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.31M
Shares Outstanding145.64K
Shares Float1.82M
Trades Count253
Dollar Volume97.28K
Avg. Volume416.24K
Avg. Weekly Volume304.96K
Avg. Monthly Volume484.60K
Avg. Quarterly Volume459.15K

Advaxis Inc. (NASDAQ: ADXS) stock closed at per share at the end of the most recent trading day (a % change compared to the prior day closing price) with a volume of 0.0000 shares and market capitalization of 9.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 18 people. Advaxis Inc. CEO is Kenneth A. Berlin.

The one-year performance of Advaxis Inc. stock is -86.17%, while year-to-date (YTD) performance is %. ADXS stock has a five-year performance of %. Its 52-week range is between 0.055 and 0.71, which gives ADXS stock a 52-week price range ratio of 1.07%

Advaxis Inc. currently has a PE ratio of -0.50, a price-to-book (PB) ratio of 0.18, a price-to-sale (PS) ratio of 0.00, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -27.03%, a ROC of -30.48% and a ROE of -30.49%. The company’s profit margin is -83.61%, its EBITDA margin is -3 053.60%, and its revenue ttm is $500.00 Thousand , which makes it $0.27 revenue per share.

Of the last four earnings reports from Advaxis Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Advaxis Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Advaxis Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Advaxis Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Advaxis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Advaxis Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 31.76, ATR14 : 0.01, CCI20 : 80.31, Chaikin Money Flow : -0.11, MACD : -0.01, Money Flow Index : 74.16, ROC : -8.82, RSI : 40.48, STOCH (14,3) : 17.65, STOCH RSI : 0.34, UO : 37.20, Williams %R : -82.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Advaxis Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
-
0.00

Advaxis Inc.

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.

CEO: Kenneth A. Berlin

Telephone: +1 609 452-9813

Address: 305 College Road East, Princeton 8540, NJ, US

Number of employees: 18

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

61%39%

Bearish Bullish

59%41%

News

Stocktwits